|

mFOLFOX6 regimen Clinical Trials

2 actively recruiting trials across 1 location

Also known as: mFOLFOX6

Pipeline

Phase 2: 1Phase 1/2: 1

Top Sponsors

  • Sixth Affiliated Hospital, Sun Yat-sen University1
  • Revolution Medicines, Inc.1

Indications

  • Cancer2
  • PDAC1
  • Rectal Adenocarcinoma1
  • High-Risk Cancer1
  • CRC1

Other1 trial

SCRT + mFOLFOX6 + PD-1 Antibody + Targeted Therapy for HIgh-Risk pMMR/MSS Rectal Cancer
Phase 2

Chandler, Arizona1 trial

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

Ironwood Cancer and Research Centers

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.